HSE have published their latest bulletins:
Biocides
- Live online workshop: biocides disinfectants efficacy (22 and 23 January 2024)
This workshop will take place over 2 half-days and will develop an understanding of the regulatory approach to efficacy assessment of disinfectant products (Main Group 1) under the GB Biocidal Products Regulations (GB BPR). It will provide a general overview of the efficacy requirements for this type of product alongside specific advice for the five product types in this group. The workshop will also address common issues related to labelling and efficacy testing for these product types. The workshop will be delivered by HSE regulatory specialists and will help attendees improve the quality of their submissions and understand how these will be reviewed by the GB regulator.
Who should attend?
The workshop is suitable for those involved in the creation and submission of efficacy data packages for disinfectant biocidal product applications, including test houses, applicants, consultants, etc.
Although no prior experience is assumed, it will specifically explore efficacy of disinfectants and will not cover other product types or general principles of efficacy assessment.
Topics covered
- general considerations affecting the labelling, testing and assessment of efficacy for disinfectant products
- specific outlines of the standard testing needed for surface disinfectants in product types 2, 3 and 4
- specific outlines of the standard testing needed for product type 1
- advice for generating adapted or novel methods for less standard products in product types 2, 3 and 4
- advice in testing for product type 5, where limited standard methods are available
- common issues and problems faced in these product types
Registration
Find out more and register for this fee paid workshop. The closing date for registration is 15 January 2024.
- Active substance no longer supported in GB
Non-approval decision to be taken for unsupported active substance in GB
Following an opportunity for any person, company or task force/consortium to support the active substance/product type combination listed below in the GB Review Programme, no dossier was received:
- 2,2-dibromo-2-cyanoacetamide (DBNPA) (CAS 10222-01-2 EC 233-539-7) in product type 02
In cases where active substance/product type combinations are not supported, GB biocides regulations require that these active substance/product type combinations are subject to a GB non-approval decision.
Once a decision is taken, biocidal products and treated articles containing this active substance in the relevant product types will have to be removed from the GB market. HSE will provide separate updates on the decision and relevant phase-out periods.
Important: If you are aware of any disproportionate negative impacts that are likely to arise from the non-approval of the active substance/product type combination listed above, please contact us by 4 February 2024.
- Upcoming GB active substance renewal submission deadlines
Under the GB Biocidal Products Regulation (GB BPR), active substance approvals will expire unless a renewal application is submitted at least 550 days before their expiry date. The 550-day deadlines are coming up for the following active substance/product type combinations under GB BPR:
- Nonanoic acid (Pelargonic acid) (CAS 112-05-0 EC 203-931-2) in product type 02
(deadline: 29 March 2024)
- 4,5-Dichloro-2-octylisothiazol-3(2H)-one (4,5-Dichloro-2-octyl-2H-isothiazol-3-one (DCOIT)) (CAS 64359-81-5 EC 264-843-8) in product type 21 (deadline: 29 June 2024)
- Bis(1-hydroxy-1H-pyridine-2-thionato-O,S)copper (Copper pyrithione) (CAS 14915-37-8 EC 238-984-0) in product type 21 (deadline: 29 June 2024)
- Copper flakes (coated with aliphatic acids) (CAS 7440-50-8 EC 231-159-6) in product type 21 (deadline: 29 June 2024)
- Copper thiocyanate (CAS 1111-67-7 EC 214-183-1) in product type 21 (deadline: 29 June 2024)
- Dichloro-N-[(dimethylamino)sulphonyl] fluoro-N-(ptolyl)methanesulphenamide (Tolylfluanid) (CAS 731-27-1 EC 211-986-9) in product type 21 (deadline: 29 June 2024)
- Dicopper oxide (CAS 1317-39-1 EC 215-270-7) in product type 21 (deadline: 29 June 2024)
- N-(Dichlorofluoromethylthio)-N′,N′-dimethyl-N-phenylsulfamide (Dichlofluanid) (CAS 1085-98-9 EC 214-118-7) in product type 21 (deadline: 29 June 2024)
- N-(trichloromethylthio)phthalimide (Folpet) (CAS 133-07-3 EC 205-088-6) in product type 06 (deadline: 29 June 2024)
- Pythium oligandrum, Chromista – Stramenopila (CAS n/a EC n/a) in product type 10
(deadline: 29 June 2024) - Zinc ethylenebis(dithiocarbamate) (polymeric) (Zineb) (CAS 12122-67-7 EC 235-180-1) in product type 21 (deadline: 29 June 2024)
- [1α(S*),3α]-(α)-cyano-(3-phenoxyphenyl)methyl 3-(2,2-dichloroethenyl)-2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate (alpha-Cypermethrin) (CAS 67375-30-8 EC 614-054-3) in product type 18 (deadline: 27 December 2024)
- Bacillus sphaericus 2362, strain ABTS-1743 (CAS 143447-72-7 EC 604-356-3) in product type 18 (deadline: 27 December 2024)
- Bacillus thuringiensis subsp. israelensis, strain SA3A (CAS n/a EC n/a) in product type 18
(deadline: 27 December 2024) - Propan-2-ol (CAS 67-63-0 EC 200-661-7) in product types 01, 02 and 04 (deadline: 27 December 2024)
- Copper, granulated (CAS 7440-50-8 EC 231-159-6) in product type 08 (deadline: 29 June 2025)
Any person, company or task force/consortium can support an active substance/product type combination for renewal – it doesn’t have to be the original supporter.
Check the GB Article 95 List to see who the original supporters were.
If any of these active substance/product type combinations are important to you, consider contacting your supplier to let them know. If a renewal application is not submitted for the above active substance/product type combinations under GB BPR, the approvals will expire. This means the active substances can no longer be used in biocidal products or treated articles of the relevant product types in GB.
- Nonanoic acid (Pelargonic acid) (CAS 112-05-0 EC 203-931-2) in product type 02
CLP
- Publication of GB mandatory classification and labelling (GB MCL) technical reports
A GB MCL technical report is an independent scientific evaluation of the information submitted under the stand-alone GB MCL process or as part of the EU harmonised classification and labelling process.
It sets out whether there is adequate scientific evidence to support a new or revised GB MCL of a substance and what that GB MCL should be.
The next batch of GB MCL technical reports is now available for download at the end of the GB MCL publication table (.xlsx).
These GB MCL technical reports relate to substances for which the Committee for Risk Assessment (RAC) published a RAC Opinion under Article 37(4) of EU CLP during 2023, based on information submitted under the EU CLP Regulation. The scientific information supporting the RAC Opinion is evaluated under the GB MCL system.
At the time of publication, the classification and labelling proposed in these technical reports has not been agreed and/or adopted in Great Britain.
For information on the next steps in the process, please see our webpage on the GB MCL system.
We expect to publish our next batch of technical reports in January 2024. CLP ebulletin alerts will be issued when technical reports are published on the HSE website.
If you have any questions or feedback on the GB MCL technical reports, please contact us at: GBCLP.GBMCL@hse.gov.uk. Journalists should contact HSE’s press office for further information.
- Publication of GB MCL Agency Opinions
A GB MCL Agency Opinion formally proposes the GB mandatory classification and labelling for chemical substances, based on the scientific and technical assessment of the scientific data in line with the GB CLP Regulation, together with an assessment of the policy and socio-economic impacts on the UK.
It sets out whether there is adequate scientific evidence to support a new or revised GB MCL of a substance and what the potential impact of the proposed GB MCL may be.
The next batch of 4 GB MCL Agency Opinions are now available for download in the GB MCL publication table (.xlsx).
These GB MCL Agency Opinions relate to substances for which HSE (as the GB CLP Agency) published an Agency Technical Report under Article 37 of the GB CLP Regulation in December 2022.
At the time of publication, the classification and labelling proposed in this Agency Opinion has not been agreed and/or adopted in Great Britain.
For information on the next steps in the process, please see our webpage on the GB MCL system.
We expect to publish our next batch of Agency Opinions in February 2024. CLP ebulletin alerts will be issued when Agency Opinions are published on the HSE website.
If you have any questions or feedback on the GB MCL Agency Opinions, please contact us at: GBCLP.GBMCL@hse.gov.uk
- ECHA public consultation: call for comments (Deadline: 9 February 2024)
The Great Britain Mandatory Classification and Labelling (GB MCL) process includes the consideration of information gathered from public consultations, conducted by HSE or international bodies such as the European Chemicals Agency (ECHA).
ECHA has announced a public consultation on the following proposal for harmonised classification and labelling (CLH):
- clethodim (ISO) (EC: -; CAS: 99129-21-2). Pesticide active substance. All hazard classes open for commenting
View the consultation on the ECHA website.
UK-based businesses with an interest in the proposal are strongly encouraged to share any relevant information. Scientific and technical information should be submitted directly to ECHA using their commenting webform by 9 February 2024. Comments will be published on ECHA’s website.
If your business is affected by the GB CLP Regulation, please also consider if you are likely to be affected by the classification and labelling proposal and let us know at an early stage if you anticipate any significant impacts or benefits.
Information on wider policy and impact considerations can be submitted to HSE at GBCLP.GBMCL@hse.gov.uk.
Under the GB CLP Regulation, HSE will consider all published opinions of the Committee of Risk Assessment of ECHA (RAC) before publishing its own Agency Technical Reports and Agency Opinions, so any information you provide will be important in any final GB MCL decision. More information on the new GB MCL system is available on the HSE website.
